Patent details
EP1545453 Title: RIFALAZIL FOR TREATING INFECTIONS OF CLOSTRIDIUM DIFFICILE
Basic Information
- Publication number:
- EP1545453
- PCT Application Number:
- PCT/US/2003/027305
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP037492881
- PCT Publication Number:
- WO/2004/019907
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- RIFALAZIL FOR TREATING INFECTIONS OF CLOSTRIDIUM DIFFICILE
- French Title of Invention:
- RIFALAZIL POUR LE TRAITEMENT D'INFECTIONS DU CLOSTRIDIUM DIFFICILE
- German Title of Invention:
- RIFALAZIL ZUR BEHANDLUNG VON INFEKTIONEN MIT CLOSTRIDIUM DIFFICILE
- SPC Number:
Dates
- Filing date:
- 29/08/2003
- Grant date:
- 18/11/2009
- EP Publication Date:
- 18/11/2009
- PCT Publication Date:
- 11/03/2004
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 29/06/2005
- EP B1 Publication Date:
- 18/11/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 29/08/2010
- Expiration date:
- 29/08/2023
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 29/08/2003
- Name:
- ActivBiotics Pharma LLC
- Address:
- 2881 Peachtree Road, NE, Unit 2204, Atlanta, GA 30305, United States (US)
Inventor
- Name:
- EISENSTEIN Barry
- Address:
- United States (US)
Priority
1
- Priority Number:
- 406873 P
- Priority Date:
- 29/08/2002
- Priority Country:
- United States (US)
2
- Priority Number:
- 444570 P
- Priority Date:
- 03/02/2003
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 9/00;
| Filing date | Document type | Number of pages |
|---|